Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 333-338

  Young, M Rita I ^a,b   Wright, Mark A ^a   Lozano, Yvonne ^a   Matthews, John P ^b   Benefield, Janet ^a   Margaret Prechel, M ^b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR BIOPSY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DINOPROSTONE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029833732     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<333::AID-IJC5>3.0.CO;2-S     Document Type: Article

References (49)

1. ALEXANDER, J.P., KUDOH, S., MELSOP, K.A., HAMILTON, T.A., EDINGER, M.G., TUBBS, R.R., SICA, D., TUASON, L., KLEIN, E., BUDOWSKI, R.M. and FINKE, J.H., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors, Cancer Res., 53, 1380-1387 (1993).
2. 2: changes in macrophage suppressor activity. J. Leukocyte Biol., 53, 550-558 (1993).
3. 2. J. Immunol., 153, 1674-1686 (1994a).
4. ALLEVA, D.G., BURGER, C.J. and ELGERT, K.D., Tumor growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-γ. Scand. J. Immunol., 39, 31-38 (1994b).
5. ALLEVA, D.G., WALKER, T.M. and ELGERT, K.D., Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β1: contrasting effects on resting and activated macrophages. J. Leukocyte Biol., 57, 919-928 (1995).
6. ANGULO, I., RODRIGUEZ, R., GARCIA, B., MEDINA, M., NAVARRO, J. and SUBIZA, J.L., Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-γ. J. Immunol., 155, 15-26 (1995).
7. ASTE-AMEZAGA, M., D'ANDREA, A., KUBIN, M. and TRINCHIERI, G., Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell- associated molecules in human T and NK cells. Cell. Immunol., 156, 480-492 (1994).
8. BERDEL, W.E., DANHAUSER-RIEDL, S., OBBRBERO, D. and ZAFFERANI, M., Effects of hematopoietic growth factors on malignant nonhematopoietic cells. Semin. Oncol., 19, 41-45 (1992).
9. CHAKRABORTY, N.G., ERGIN, M.T. and MUKHERJI, B., Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2. In Vivo, 5, 631-635 (1991).
10. CLAYMAN, G.L., TAYLOR, D.L., LIU, F.J., LAVEDAN, P., SAVAGE, H.E. and SCHANTZ, S.P., Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells. Laryngoscope, 103, 299-307 (1993).
11. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D. and MULLIGAN, R.C., Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. nat. Acad. Sci. (Wash.), 90, 3539-3543 (1993).
12. FIELD, E.H. and BECKER, G.C., Blocking of mixed lymphocyte reaction by spleen cells from total lymphoid-irradiated mice involves interruption of the IL-2 pathway. J. Immunol., 148, 354-359 (1992).
13. HADDEN, J.W., ENDICOTT, J., BAEKEY, P., SKIPPER, P. and HADDEN, E.M., Interleukins and contrasuppression induce immune regression of head and neck cancer. Arch. Otolaryngol., 120, 395-403 (1994).
14. HUBER, D., PHILIPP, J. and FONTANA, A., Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J. Immunol., 148, 277-284 (1992).
15. INGE, T.H., HOOVER, S.K., FRANK, J.L., KAWABATA, T.T., BETHKE, K.P. and BEAR, H.D., Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide. Cancer Immunol. Immunother., 35, 119-126 (1992).
16. JORASCHKEWITZ, M., DEPENBROCK, H., FREUND, M., ERDMANN, G., MEYER, H.-J., DE RIESE, W., NEUKAM, D., HANAUSKE, U., KRUMWIEH, M., POLIWODA, H. and HANAUSKE, A.-R., Effects of cytokines on in vitro colony formation of primary human tumour specimens. Europ. J. Cancer, 26, 1070-1074 (1992).
17. KATZ, A.E., Update on immunology of head and neck cancer. Med. Clin. N. Amer., 77, 625-631 (1993).
18. KHOO, N.K., CHAN, F.P., SAARLOOS, M.N. and LALA, P.K., Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2. Clin. exp. Metastasis, 10, 239-252 (1992).
19. KOYAMA, S. and FUKAO, K., Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma. J. Cancer Res. clin. Oncol., 120, 240-247 (1994).
20. LAKHDAR, M., BEN ARIBIA, M.H., MAALEJ, M. and LADGHAM, A., Selective horning of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor. Int. J. Cancer, 48, 57-61 (1991).
21. LANG, S.H., MILLER, W.R., DUNCAN, W. and HABIB, F.K., Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Int. J. Cancer, 59, 235-241 (1994).
22. LAPOINTE, H., LAMPE, H. and BANERJEE, D., Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses. Otolaryngology, 106, 149-158 (1992).
23. LETESSIER, E.M., SACCHI, M., JOHNSON, J.T., HERBERMAN, R.B. and WHITESIDE, T.L., The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer. Cell. Immunol., 130, 446-458 (1990).
24. + T cells. J. Immunol., 149, 949-956 (1992).
25. MAEDA, H., KUWAHARA, H., ICHIMURA, Y., OHTSUKI, M., KURAKATA, S. and SHIRAISHI, A., TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol., 155, 4926-4932 (1995).
26. MAEDA, N. and SAGARA, Y., Analysis of immunosuppressive mechanism to cytotoxic T lymphocyte generation in patients with advanced cancer. Asia-Oceania J. Obstet. Gynaecol., 19, 309-318 (1993).
27. MCGRATH, P.C., HAMBY, L.S. and FREEMAN, J.W., Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer. Amer. J. Surg., 164, 610-614 (1992).
28. MOORE, S.C., THEUS, S.A., BARNETT, J.B. and SODERBERG, L.S., Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell. Immunol., 141, 398-408 (1992).
29. H2 responses. Immunol. Today, 12, A49-A53 (1991).
30. O'MAHONY, A.M., O'SULLIVAN, G.C., O'CONNELL, J., COTTER, T.G. and COLLINS, J.K., An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol., 151, 4847-4856 (1993).
31. 2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF. J. Leukocyte Biol., 53, 86-92 (1993).
32. PAVEL, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B. and KIESSLING, R., Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. nat. Acad. Sci. (Wash.), 89, 7708-7712 (1992).
33. RABINOWICH, H., VITOLO, D., ALTARAC, S., HERBERMAN, R.B. and WHITESIDE, T.L., Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J. Immunol., 149, 340-349 (1992).
34. RICE, S.Q., CRANE, I.J., SCULLY, C. and PRIME, S.S., Production of a suppressor of lymphocyte proliferation by two human oral carcinoma cell lines. Scand. J. Immunol., 36, 443-452 (1992).
35. SAWYERS, C.L., GOLDE, D.W., QUAN, S. and NIMER, S.D., Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia. Cancer, 69, 1342-1346 (1992).
36. SCHMIDT-WOLF, I.G., DEJBAKHSH-JONES, S., GINZTON, N., GREENBERG, P. and STROBER, S., T-cell subsets and suppressor cells in human bone marrow. Blood, 80, 3242-3250 (1992).
37. SOTOMAYOR, E.M., FU, Y.-X., LOPEZ-CEPERO, M., HERBERT, L., JIMENEZ, J.J., ALBARRACIN, C. and LOPEZ, D.M., Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor. J. Immunol., 147, 2816-2823 (1991).
38. STANOJEVIC-BAKI, N., VUCKOVIC-DEKIC, L., SUSNJAR, S. and SPUZIC, I., In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients. Neoplasma, 39, 129-132 (1992).
39. STEWART, T.H., HOLLINSHEAD, A.C. and RAMAN, S., Tumour dormancy: initiation, maintenance and termination in animals and humans. Canad. J. Surg., 34, 321-325 (1991).
40. TAITZ, A., PETRUZZELLI, G., PAK, A.S., WRIGHT, M.A., MATTHEWS, J.P., RASLAN, W.F., LOZANO, Y. and YOUNG, M.R.I., Immune parameters of mice bearing human head and neck cancer. Cancer Immunol. Immunother., 40, 283-291 (1995).
41. VLOCK, D.R., Immunobiologic aspects of head and neck cancer. Hematol. Oncol. Clin. N. Amer., 5, 797-820 (1991).
42. WANEBO, H.J., BLACKINTON, D., KOUTTAB, N. and MEHTA, S., Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer. Amer. J. Surg., 166, 389-394 (1993).
43. YOUNG, M.R.I., YOUNG, M.E. and WRIGHT, M.A., Stimulation of immune suppressive bone marrow cells by colony stimulating factors. Exp. Hematol., 18, 806-811 (1990).
44. 3 plus γ-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells. Cancer Res., 53, 6006-6010 (1993).
45. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin. Cancer Res., 1, 95-103 (1995).
46. YOUNG, M.R.I. and WRIGHT, M.A., Myeloppiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce immune suppressor and tumor growth-promoting activities of bone marrow cells, and diminish tumor recurrence and metastasis. Cancer Res., 52, 6335-6340 (1992).
47. YOUNG, M.R.I., WRIGHT, M.A., MATTHEWS, J.P., MALIK, I. and PRECHEL, M., Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide. J. Immunol., (1996). (in press).
48. YOUNG, M.R.I., YOUNG, M.E. and WRIGHT, M.A., Stimulation of immune suppressive bone marrow cells by colony stimulating factors. Exp. Hematol., 18, 806-811 (1990).
49. + tumor-infiltrating lymphocytes from human lung carcinomas. Europ. J. Immunol., 20, 2685-2689 (1990).